Description of a Novel Mechanism Possibly Explaining the Antiproliferative Properties of Glucocorticoids in Duchenne Muscular Dystrophy Fibroblasts Based on Glucocorticoid Receptor GR and NFAT5
Glucocorticoids are drugs of choice in Duchenne muscular dystrophy (DMD), prolonging patients’ ambulation. Their mode of action at the protein level is not completely understood. In DMD, muscle tissue is replaced by fibrotic tissue produced by fibroblasts, reducing mobility. Nuclear factor of activa...
Main Authors: | Sandrine Herbelet, Boel De Paepe, Jan L. De Bleecker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/23/9225 |
Similar Items
-
Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents
by: Sandrine Herbelet, et al.
Published: (2020-06-01) -
The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target
by: Sandrine Herbelet, et al.
Published: (2021-03-01) -
Clinical analysis of 155 patients with Duchenne muscular dystrophy
by: Qi BING, et al.
Published: (2015-05-01) -
Growth pattern trajectories in boys with Duchenne muscular dystrophy
by: Georgia Stimpson, et al.
Published: (2022-01-01) -
Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy
by: C. L. Wood, et al.
Published: (2019-04-01)